Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials

References

• ButrusSPortelaROcular allergy: diagnosis and treatmentOphthalmol Clin North Am200518448549216314214
   PubMedGoogle Scholar
• KatelarisCHBieloryLEvidence-based study design in ocular allergy trialsCurr Opin Allergy Clin Immunol20088548448818769206
   PubMed Web of Science ®Google Scholar
• RosarioNBieloryLEpidemiology of allergic conjunctivitisCurr Opin Allergy Clin Immunol201111547147621785348
   PubMed Web of Science ®Google Scholar
• WongAHBargSSLeungAKSeasonal and perennial allergic conjunctivitisRecent Pat Inflamm Allergy Drug Discov20148213915325000933
   PubMedGoogle Scholar
• BieloryLOcular allergy overviewImmunol Allergy Clin North Am2008281123v18282543
   PubMed Web of Science ®Google Scholar
• La RosaMLionettiEReibaldiMAllergic conjunctivitis: a comprehensive review of the literatureItal J Pediatr2013391823497516
   PubMed Web of Science ®Google Scholar
• AbelsonMBSmithLChapinMOcular allergic disease: mechanisms, disease sub-types, treatmentOcul Surf20031312714917075644
   PubMedGoogle Scholar
• AkdisCABlaserKHistamine in the immune regulation of allergic inflammationJ Allergy Clin Immunol20031121152212847474
   PubMed Web of Science ®Google Scholar
• LeonardiABogackaEFauquertJLOcular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surfaceAllergy201267111327133722947083
   PubMed Web of Science ®Google Scholar
• UdellIJAbelsonMBAnimal and human ocular surface response to a topical nonimmune mast-cell degranulating agent (compound 48/80)Am J Ophthalmol19819122262306162389
   PubMed Web of Science ®Google Scholar
• AbelsonMBUdellIJH2-receptors in the human ocular surfaceArch Ophthalmol19819923023046451212
   PubMedGoogle Scholar
• SmithJAMansfieldLEde ShazoRDNelsonHSAn evaluation of the pharmacologic inhibition of the immediate and late cutaneous reaction to allergenJ Allergy Clin Immunol1980652118121
   Web of Science ®Google Scholar
• GomesPJTrends in prevalence and treatment of ocular allergyCurr Opin Allergy Clin Immunol201414545145625115683
   PubMed Web of Science ®Google Scholar
• OffiahICalderVLImmune mechanisms in allergic eye diseases: what is new?Curr Opin Allergy Clin Immunol20099547748119620858
   PubMed Web of Science ®Google Scholar
• VirchowJCKaySDemolyPMullolJCanonicaWHigginsVImpact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients – an observational, cross sectional study in four countries in EuropeJ Med Econ201114330531421488807
   PubMedGoogle Scholar
• BlaissMSAllergic rhinoconjunctivitis: burden of diseaseAllergy Asthma Proc200728439339717883905
   PubMed Web of Science ®Google Scholar
• PalmaresJDelgadoLCidadeMQuadradoMJFilipeHPAllergic conjunctivitis: a national cross-sectional study of clinical characteristics and quality of lifeEur J Ophthalmol201020225726420037906
   PubMed Web of Science ®Google Scholar
• Lastacaft (alcaftadine ophthalmic solution) 0.25% [Package insert]Irvine, CAAllergan Inc2011
   Google Scholar
• Gallois-BernosAThurmondRLPharmacology of alcaftadine, a new antihistamine for ocular allergyInvest Ophthalmol Vis Sci201152e6426
   Google Scholar
• GreinerJVEdwards-SwansonKIngermanAEvaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%Clin Ophthalmol20115879321339800
   PubMedGoogle Scholar
• TorkildsenGSheddenAThe safety and efficacy of alcaftadine 0.25% ophthalmic solution for the prevention of itching associated with allergic conjunctivitisCurr Med Res Opin201127362363121250860
   PubMed Web of Science ®Google Scholar
• AckermanSD’AmbrosioFJrGreinerJVVillanuevaLCiolinoJBHollanderDAA multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge modelJ Asthma Allergy20136435224109191
   PubMedGoogle Scholar
• McLaurinEBMarsicoNPCiolinoJBWilliamsJMHollanderDAAlcaftadine 025% versus Olopatadine 02% in the Prevention of Ocular Itching in Allergic ConjunctivitisBaltimore, MDPaper presented at: Annual Scientific MeetingNovember 7–11, 2013American College of Allergy, Asthma and Immunology2013
   Google Scholar
• McLaurinEBMarsicoNPCiolinoJBWilliamsJMHollanderDAAlcaftadine 0.25% versus Olopatadine 0.2% in Prevention of Ocular Itching Due to Allergic Conjunctivitis in a CAC™ ModelNew Orleans, LAPaper presented at: Annual MeetingNovember 16–19, 2013American Academy of Ophthalmology2013
   Google Scholar
• McLaurinEBMarsicoNPAckermanSLOcular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trialsAdv Ther201431101059107125260889
   PubMed Web of Science ®Google Scholar
• ScoperSVBerdyGJLichtensteinSJPerception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitisAdv Ther20072461221123218165204
   PubMed Web of Science ®Google Scholar
• StillermanANachtsheimCLiWAlbrechtMWaldmanJEfficacy of a novel air filtration pillow for avoidance of perennial allergens in symptomatic adultsAnn Allergy Asthma Immunol2010104544044920486336
   PubMed Web of Science ®Google Scholar
• NamdarRValdezCAlcaftadine: a topical antihistamine for use in allergic conjunctivitisDrugs Today (Barc)2011471288389022348913
   PubMed Web of Science ®Google Scholar
• WadeLBieloryLRudnerSOphthalmic antihistamines and H1-H4 receptorsCurr Opin Allergy Clin Immunol201212551051622918191
   PubMed Web of Science ®Google Scholar
• LingPNgoKNguyenSHistamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulationBr J Pharmacol2004142116117115131002
   PubMed Web of Science ®Google Scholar
• ThurmondRLGelfandEWDunfordPJThe role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistaminesNat Rev Drug Discov200871415318172439
   PubMed Web of Science ®Google Scholar